Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

United States Hepatitis B Market and Competitive Landscape Highlights 2010-2020: Focus on Pipeline, Epidemiology, Products, Sales, Valuations & Market Share - Research and Markets

Research and Markets
Posted on: 05 Oct 16

Research and Markets has announced the addition of the "US Hepatitis B Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

US Hepatitis B Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Hepatitis B pipeline products, Hepatitis B epidemiology, Hepatitis B market valuations and forecast, Hepatitis B products sales and competitive landscape in the US.

The research is classified into nine sections - Hepatitis B overview including etiology, pathophysiology, and diagnosis, Hepatitis B treatment options, Hepatitis B pipeline products, Hepatitis B market analysis comprising of Hepatitis B epidemiology, key products marketed for Hepatitis B, market valuations and forecast, products sales and market shares.

Research Scope:

  • Hepatitis B Pipeline: Find out the products in clinical trials for the treatment of Hepatitis B by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Hepatitis B Epidemiology: Find out the number of patients diagnosed (prevalence) with Hepatitis B in the US
  • Hepatitis B Products: Identify key products marketed and prescribed for Hepatitis B in the US, including trade name, molecule name, and company
  • Hepatitis B Product Sales: Find out the sales revenues of Hepatitis B products, both branded and generics, in the US
  • Hepatitis B Market Valuations: Find out the market size for Hepatitis B products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
  • Hepatitis B Products Market Share: Find out the market shares for key Hepatitis B products in the US

Key Topics Covered:

  1. Disease Overview
  2. Hepatitis B Treatments
  3. Hepatitis B Pipeline
  4. US Hepatitis B Epidemiology
  5. Marketed Drugs for Hepatitis B in US
  6. US Hepatitis B Market Size
  7. US Hepatitis B Products Sales
  8. US Hepatitis B Market Competitive Landscape
  9. US Hepatitis B Market Forecast

For more information about this drug pipelines report visit

View source version on

Business Wire

Last updated on: 05/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.